Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss
Glucagon receptor adaptation may take slightly longer because fewer tissues in the body have adapted to exogenous glucagon agonism previously
5 , 189 (2016) Acknowledgements This work was supported by the National Natural Science Foundation of China grants 31330019 (Z.-J.L.), 31500593 (G.S.), 81373463 and 81573479 (D.Y.), the National Health and Family Planning Commission grants 2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507001 and 2013ZX09507-002 (M.-W.W.), Shanghai Science and Technology Development Fund 15DZ2291600 (M.-W.W.), and Ministry of Science and Technology of China grants 2014CB910400 (Z.-J.L.) and 2015CB910104 (Z.-J.L.), the Netherlands eScience Center (NLeSC)/NWO Enabling Technologies project: 3D-e-Chem, grant 027.014.201 (C.d.G.), the European Cooperation in Science and Technology Action CM1207 GLISTEN (C.d.G.), and National Key Research and Development Program of China 2016YCF0905902 (S.Z.)
Finally, location within Los Angeles County can influence pricing
Some plans offering tiered options For employer-sponsored plans, some insurers are offering tiered options: Opt-in coverage: Employers can choose to cover GLP-1 drugs at an added cost
US$ 24.41
US$ 20.93
US$ 25.52
US$ 28.94
US$ 28.08
US$ 29.59
US$ 27.57
US$ 20.80
